US Patent 11559501 Transdermal amphetamine compositions with low levels of carbamate
Patent 11559501 was granted and assigned to Noven Pharmaceuticals on January, 2023 by the United States Patent and Trademark Office.
All edits
Edits on 8 May, 2024
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Patent Citations Received
Edits on 25 Oct, 2023
Golden AI
Edits made to:
Infobox (+3 properties)
Infobox
Patent Inventor Names
Atsushi Sonobe0
Deboprosad Mondal0
Naruhito Higo0
Edits on 6 Apr, 2023
Golden AI
Infobox
Edits on 23 Mar, 2023
Golden AI
Infobox
Edits on 25 Jan, 2023
Golden AI
Edits made to:
Infobox (+13 properties)
Article (+262 characters)
US Patent 11559501 Transdermal amphetamine compositions with low levels of carbamate
Article
Described are methods for reducing the formation of amphetamine carbamate and amphetacarbamate in transdermal amphetamine compositions, compositions with low levels of amphetacarbamate, and methods using such compositions for transdermal delivery of amphetamine.
Infobox
Is a
Patent Applicant
Current Assignee
Patent Jurisdiction
Patent Number
115595010
Date of Patent
January 24, 2023
0Patent Application Number
175698620
Date Filed
January 6, 2022
0Patent Citations
Patent Primary Examiner
Find more entities like US Patent 11559501 Transdermal amphetamine compositions with low levels of carbamate
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
